Prof. Dr. Gerhard Krönke

Medizinische Fakultät Professur für Modulation von Immunantworten Department of Medicine 3 – Rheumatology and Immunology

Optoacoustic Imaging in Inflammation (2021) Regensburger A, Brown E, Krönke G, Waldner M, Knieling F Journal article, Review article Upregulation of CCR4 in activated CD8(+) T cells indicates enhanced lung homing in patients with severe acute SARS-CoV-2 infection (2021) Spoerl S, Kremer A, Aigner M, Eisenhauer N, Koch P, Meretuk L, Loeffler P, et al. Journal article Hydroxyapatite-Coated SPIONs and Their Influence on Cytokine Release (2021) Friedrich B, Auger JP, Dutz S, Cicha I, Schreiber E, Band J, Boccaccini AR, et al. Journal article Humoral and Cellular Immune Responses to SARS–CoV-2 Infection and Vaccination in Autoimmune Disease Patients With B Cell Depletion (2021) Simon D, Tascilar K, Schmidt K, Manger B, Weckwerth L, Sokolova M, Bucci L, et al. Journal article Protektive Makrophagen: Neue Einblicke zur Rolle von Synovialmakrophagen bei entzündlichen Gelenkerkrankungen (2021) Knab K, Chambers D, Krönke G Journal article SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases (2021) Simon D, Tascilar K, Fagni F, Krönke G, Kleyer A, Meder C, Meder C, et al. Journal article The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts (2021) Friščić J, Böttcher M, Reinwald C, Bruns H, Wirth B, Popp S, Walker KI, et al. Journal article, Original article An advanced optical clearing protocol allows label-free detection of tissue necrosis via multiphoton microscopy in injured whole muscle (2021) Schneidereit D, Broellochs A, Ritter P, Kreiß L, Mokhtari Z, Beilhack A, Krönke G, et al. Journal article, Original article Metabolic reprogramming of osteoclasts represents a therapeutic target during the treatment of osteoporosis (2020) Taubmann J, Krishnacoumar B, Böhm C, Faas M, Müller D, Adam S, Stoll C, et al. Journal article Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion (2020) Simon D, Tascilar K, Krönke G, Kleyer A, Zaiss M, Heppt F, Meder C, et al. Journal article